05/24/2013

Studies Question Potential Alzheimer’s Treatment

12:19 minutes

Last year scientists reported that a skin cancer drug appeared to reverse the effects of an Alzheimer’s-like disease in mice. But four studies out this week in Science question the original results. Ronald Petersen, director of the Mayo Clinic’s Alzheimer’s Disease Research Center, talks about the new findings, and the hunt for Alzheimer’s drugs.

Segment Guests

Ronald Petersen

Ronald Petersen is chair of the Advisory Council for the National Alzheimer’s Project Act and director of the Mayo Alzheimer’s Disease Research Center at the Mayo Clinic in Rochester, Minnesota.

Meet the Producer

About Christopher Intagliata

Christopher Intagliata is Science Friday’s senior producer. He once served as a prop in an optical illusion and speaks passable Ira Flatowese.

Explore More

Against the Grain: An Alternative View of Alzheimer’s

For decades, Duke neurology professor Allen Roses has doggedly pursued a theory that dysfunctional mitochondria in the brain cause late-onset Alzheimer's disease, and that beta-amyloid is just part...

Read More